Clinical Trials in Shiga, Japan
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Factor Xa InhibitorLife Threatening Bleeding
AstraZeneca300 enrolled66 locationsNCT05454787
Recruiting
Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Rheumatoid Arthritis (RA)
Astellas Pharma Inc3,000 enrolled47 locationsNCT03971253
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
Diabetes Mellitus, Type 1
Novo Nordisk A/S630 enrolled80 locationsNCT06807190
Recruiting
Phase 3
ONO-4059 Study in Patients With Steroid-resistant Pemphigus
PemphigusSteroid-resistant Pemphigus
Ono Pharmaceutical Co., Ltd.34 enrolled25 locationsNCT06696716
Recruiting
Phase 2
Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures
Epilepsies, Partial
Ono Pharmaceutical Co., Ltd.100 enrolled29 locationsNCT06590896
Recruiting
Zephyr Valve Japan Post-Marketing Surveillance
COPDEmphysemaSevere Emphysema
Pulmonx Corporation140 enrolled17 locationsNCT06332885